Mp alpha1 receptor: Clinical Trials

4 trials of Mp alpha1 receptor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 3, Terminated 1
Phase 12Completed 2

Follow Mp alpha1 receptor: new trials by email Literature Review of Mp alpha1 receptor trials Research Report on Mp alpha1 receptor

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Long-term Safety of Alpha1-Proteinase Inhibitor (Human) in Japanese Subjects With Alpha1 Antitrypsin Deficiency (GTI1401-OLE)
Alpha-1 MP - Alpha1-Antitrypsin Deficiency
Phase 1 / Phase 2CompletedGrifols Therapeutics LLC42016-07-292022-03-31
Safety and Pharmacokinetics of Alpha-1 MP (Alpha1-proteinase Inhibitor (Human), Modified Process) in Participants With Alpha1-Antitrypsin Deficiency
Alpha-1 MP - Alpha1-Antitrypsin Deficiency
Phase 1 / Phase 2CompletedGrifols Therapeutics LLC42016-07-292021-10-28
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
180 mg/kg Alpha1-PI, 90 mg/kg Alpha1-PI, Placebo - Type 1 Diabetes Mellitus
Phase 2TerminatedGrifols Therapeutics LLC762014-03-012018-09-05
Safety and Pharmacokinetics of Alpha-1 Proteinase Inhibitor in Subjects With Alpha1-Antitrypsin Deficiency
Prolastin-C, 60 mg/kg, Prolastin-C, 120 mg/kg - Emphysema, Alpha 1-antitrypsin Deficiency (AATD)
Phase 2CompletedGrifols Therapeutics LLC302010-11-012013-05-20

Conditions studied

alpha 1-Antitrypsin Deficiency (4)  ·  Diabetes Mellitus, Type 1 (1)  ·  Emphysema (1)

Sponsors

Grifols Therapeutics LLC (4)

Countries

Japan (2)  ·  United States (2)

Top investigators

Charlie Strange, MD (1)  ·  Friedrich Kueppers, MD (1)  ·  James Stocks, MD (1)  ·  Mark Brantly, MD (1)  ·  Michael Campos, MD (1)

Results publications

PMID 30416054, PMID 33244872, PMID 35970714